Marinus Pharmaceuticals reported -19169000 in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -15301000 28.41M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
ALKERMES ALKS:US -19659000 24.08M
Amgen AMGN:US $ 2378M 45M
Aptinyx Inc APTX:US $ -21206000 1.34M
Arena Pharmaceuticals ARNA:US $ -124485000 19.91M
Biogen BIIB:US $ 858.6M 171.5M
Eisai 4523:JP 5.5B 49.91B
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Gilead Sciences GILD:US $ 3883M 1637M
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
Intra Cellular Therapies ITCI:US $ -77323830 8.18M
Marinus Pharmaceuticals MRNS:US -19169000 4.32M
Minerva Neurosciences NERV:US $ -7517620 1.45M
Neurocrine Biosciences NBIX:US $ 44.5M 23.3M
Ptc Therapeutics PTCT:US $ -93076000 5.42M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sarepta Therapeutics SRPT:US $ -34458000 133.12M
Supernus Pharmaceuticals SUPN:US $ 32.6M 1.51M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M
YTE INCY:US $ 247.47M 92.16M
Zogenix ZGNX:US $ -53870000 1.56M